{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:47:28Z","timestamp":1780523248448,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12011-011-9003-3","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T17:35:54Z","timestamp":1299000954000},"page":"1424-1434","source":"Crossref","is-referenced-by-count":12,"title":["Valproic Acid Modulates Superoxide Dismutase, Uric Acid-Independent FRAP and Zinc in Blood of Adult Epileptic Patients"],"prefix":"10.1007","volume":"143","author":[{"given":"El\u017cbieta","family":"P\u0142onka-P\u00f3\u0142torak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Zagrodzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Ch\u0142opicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Barto\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Westermarck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Kaipainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faik","family":"Atroshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"9003_CR1","first-page":"225","volume":"15","author":"J Majkowski","year":"2007","unstructured":"Majkowski J (2007) Epileptogenesis\u2014the role of oxygen stress. Epileptologia 15:225\u2013240","journal-title":"Epileptologia"},{"key":"9003_CR2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.ejcn.1602615","volume":"61","author":"S Haldar","year":"2007","unstructured":"Haldar S, Rowland IR, Barnett YA et al (2007) Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores. Eur J Clin Nutr 61:1011\u20131022","journal-title":"Eur J Clin Nutr"},{"key":"9003_CR3","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s11064-007-9386-x","volume":"32","author":"M Naz\u0131ro\u011flu","year":"2007","unstructured":"Naz\u0131ro\u011flu M (2007) New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem Res 32:1990\u20132001","journal-title":"Neurochem Res"},{"key":"9003_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000098053","volume":"57","author":"A Ay\u00e7i\u00e7ek","year":"2007","unstructured":"Ay\u00e7i\u00e7ek A, I\u015fcan A (2007) The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Eur Neurol 57:65\u201369","journal-title":"Eur Neurol"},{"key":"9003_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0891-5849(92)90070-W","volume":"13","author":"D Torbati","year":"1992","unstructured":"Torbati D, Church DF, Keller JM, Pryor WA (1992) Free radical generation in the brain precedes hyperbaric oxygen induced convulsions. Free Radic Biol Med 13:101\u2013106","journal-title":"Free Radic Biol Med"},{"key":"9003_CR6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4522(02)00655-3","volume":"116","author":"JF Wang","year":"2003","unstructured":"Wang JF, Azzam JE, Young LT (2003) Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience 116:485\u2013489","journal-title":"Neuroscience"},{"key":"9003_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0009-8981(00)00337-5","volume":"303","author":"K Sudha","year":"2001","unstructured":"Sudha K, Rao AV, Rao A (2001) Oxidative stress and antioxidants in epilepsy. Clin Chim Acta 303:19\u201324","journal-title":"Clin Chim Acta"},{"key":"9003_CR8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1254\/jphs.FPJ04032X","volume":"96","author":"SA Hamed","year":"2004","unstructured":"Hamed SA, Abdellah MM, El-Melegy N (2004) Blood levels of trace elements, electrolytes, and oxidative stress\/antioxidant system in epileptic patients. J Pharmacol Sci 96:465\u2013473","journal-title":"J Pharmacol Sci"},{"key":"9003_CR9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","volume":"78","author":"A Verrotti","year":"2008","unstructured":"Verrotti A, Scardapane A, Franzoni E, Manco R, Chiarelli F (2008) Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 78:171\u2013177","journal-title":"Epilepsy Res"},{"key":"9003_CR10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eplepsyres.2009.02.003","volume":"84","author":"U Yi\u015f","year":"2009","unstructured":"Yi\u015f U, Se\u00e7kin E, Kurul SH, Kuralay F, Dirik E (2009) Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy. Epilepsy Res 84:232\u2013237","journal-title":"Epilepsy Res"},{"key":"9003_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389\u2013399","journal-title":"Epilepsia"},{"key":"9003_CR12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IF Benzie","year":"1996","unstructured":"Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay. Anal Biochem 239:70\u201376","journal-title":"Anal Biochem"},{"key":"9003_CR13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/mds.21502","volume":"22","author":"T Annanmaki","year":"2007","unstructured":"Annanmaki T, Muuronen A, Murros K (2007) Low plasma uric acid level in Parkinson's disease. Mov Disord 22:1133\u20131137","journal-title":"Mov Disord"},{"key":"9003_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0034-5288(98)90127-8","volume":"64","author":"P Zagrodzki","year":"1998","unstructured":"Zagrodzki P, Nicol F, McCoy MA et al (1998) Iodine deficiency in cattle: compensatory changes in thyroidal selenoenzymes. Res Vet Sci 64:209\u2013211","journal-title":"Res Vet Sci"},{"key":"9003_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/978-1-4615-4717-4_54","volume":"471","author":"IR Siska","year":"1999","unstructured":"Siska IR, Avram J, Tatu C, Bunu C, Schneider F, Maties R (1999) Some aspects concerning the antioxidant capacity of venous blood in lower limbs varicose veins. Adv Exp Med Biol 471:445\u2013452","journal-title":"Adv Exp Med Biol"},{"key":"9003_CR16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1006\/abio.1993.1521","volume":"214","author":"C Nebot","year":"1993","unstructured":"Nebot C, Moutet M, Huet P, Xu JZ, Yadan JC, Chaudiere J (1993) Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem 214:442\u2013451","journal-title":"Anal Biochem"},{"key":"9003_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"key":"9003_CR18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1592\/phco.21.20.1549.34480","volume":"21","author":"SA Chapman","year":"2001","unstructured":"Chapman SA, Wacksman GP, Patterson BD (2001) Pancreatitis associated with valproic acid: a review of the literature. Pharmacotherapy 21:1549\u20131560","journal-title":"Pharmacotherapy"},{"key":"9003_CR19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/clinchem\/35.7.1348","volume":"35","author":"CE Pippenger","year":"1989","unstructured":"Pippenger CE, Meng X, Van Lente F, Rotliner AD (1989) Valproate therapy depresses GSHpX and SOD enzyme activity. A possible mechanism for valproate induced idiosyncratic drug toxicity. Clin Chem 35:1173","journal-title":"Clin Chem"},{"key":"9003_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.1320570222","volume":"57","author":"P Maertens","year":"1995","unstructured":"Maertens P, Dyken P, Graf W et al (1995) Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses. Am J Med Genet 57:225\u2013228","journal-title":"Am J Med Genet"},{"key":"9003_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/BTER:102:1-3:001","volume":"102","author":"F Armutcu","year":"2004","unstructured":"Armutcu F, Ozerol E, Gurel A et al (2004) Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children. Biol Trace Elem Res 102:1\u201310","journal-title":"Biol Trace Elem Res"},{"key":"9003_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/JBCPP.2000.11.1.73","volume":"11","author":"A Y\u00fcksel","year":"2000","unstructured":"Y\u00fcksel A, Cengiz M, Seven M, Ulutin T (2000) Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. J Basic Clin Physiol Pharmacol 11:73\u201381","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"9003_CR23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/088307380201700904","volume":"17","author":"D Turkdogan","year":"2002","unstructured":"Turkdogan D, Toplan S, Karakoc Y (2002) Lipid peroxidation and antioxidative enzyme activities in childhood epilepsy. J Child Neurol 17:673\u2013676","journal-title":"J Child Neurol"},{"key":"9003_CR24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/phrs.1999.0603","volume":"41","author":"M Cengiz","year":"2000","unstructured":"Cengiz M, Y\u00fcksel A, Seven M (2000) The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol Res 41:423\u2013425","journal-title":"Pharmacol Res"},{"key":"9003_CR25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0920-1211(01)00322-9","volume":"48","author":"A Verrotti","year":"2002","unstructured":"Verrotti A, Basciani F, Trotta D et al (2002) Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1\u00a0year of sodium valproate and carbamazepine therapy. Epilepsy Res 48:71\u201375","journal-title":"Epilepsy Res"},{"key":"9003_CR26","first-page":"991","volume":"37","author":"E Solowiej","year":"2003","unstructured":"Solowiej E, Sobaniec W (2003) The effect of antiepilepticdrug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy. Neurol Neurochir Pol 37:991\u20131003","journal-title":"Neurol Neurochir Pol"},{"key":"9003_CR27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10522-006-9054-6","volume":"7","author":"E Mariani","year":"2006","unstructured":"Mariani E, Cornacchiola V, Polidori MC et al (2006) Antioxidant enzyme activities in healthy old subjects: influence of age, gender and zinc status: results from the Zincage Project. Biogerontology 7:391\u2013398","journal-title":"Biogerontology"},{"key":"9003_CR28","first-page":"19","volume":"492","author":"S Marklund","year":"1980","unstructured":"Marklund S (1980) Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol Scand Suppl 492:19\u201323","journal-title":"Acta Physiol Scand Suppl"},{"key":"9003_CR29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jnutbio.2005.03.009","volume":"16","author":"WT Johnson","year":"2005","unstructured":"Johnson WT, Johnson LA, Lukaski HC (2005) Serum superoxide dismutase 3 (extracellular superoxide dismutase) activity is a sensitive indicator of Cu status in rats. J Nutr Biochem 16:682\u2013692","journal-title":"J Nutr Biochem"},{"key":"9003_CR30","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1017\/S0007114508006806","volume":"99","author":"LJ Harvey","year":"2008","unstructured":"Harvey LJ, McArdle HJ (2008) Biomarkers of copper status: a brief update. Brit J Nutr 99:S10\u2013S13","journal-title":"Brit J Nutr"},{"key":"9003_CR31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35\u00a0years of clinical experience. CNS Drugs 16:695\u2013714","journal-title":"CNS Drugs"},{"key":"9003_CR32","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.WCB.0000138666.25305.A7","volume":"24","author":"C Morland","year":"2004","unstructured":"Morland C, Boldingh KA, Iversen EG, Hassel B (2004) Valproate is neuroprotective against malonate toxicity in rat striatum: an association with augmentation of high-affinity glutamate uptake. J Cereb Blood Flow Metab 24:1226\u20131234","journal-title":"J Cereb Blood Flow Metab"},{"key":"9003_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00221-002-1224-4","volume":"147","author":"Y Ueda","year":"2002","unstructured":"Ueda Y, Yokoyama H, Nakajima A et al (2002) Glutamate excess and free radical formation during and following kainic acid-induced status epilepticus. Exp Brain Res 147:219\u2013226","journal-title":"Exp Brain Res"},{"key":"9003_CR34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.exger.2007.10.012","volume":"43","author":"E Mariani","year":"2008","unstructured":"Mariani E, Mangialasche F, Feliziani FT et al (2008) Effects of zinc supplementation on antioxidantenzyme activities in healthy old subjects. Exp Gerontol 43:445\u2013451","journal-title":"Exp Gerontol"},{"key":"9003_CR35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/07315724.2006.10719537","volume":"25","author":"S Hughes","year":"2006","unstructured":"Hughes S, Samman S (2006) The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J Am Coll Nutr 25:285\u2013291","journal-title":"J Am Coll Nutr"},{"key":"9003_CR36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1528-1157.1995.tb02574.x","volume":"36","author":"AE K\u00fcrek\u00e7i","year":"1995","unstructured":"K\u00fcrek\u00e7i AE, Alpay F, Tanindi S et al (1995) Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia 36:600\u2013604","journal-title":"Epilepsia"},{"key":"9003_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archneur.1974.00490310054009","volume":"30","author":"A Barbeau","year":"1974","unstructured":"Barbeau A, Donaldson J (1974) Zinc, taurine, and epilepsy. Arch Neurol 30:52\u201358","journal-title":"Arch Neurol"},{"key":"9003_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000480986","volume":"5","author":"A Higashi","year":"1982","unstructured":"Higashi A, Ikeda T, Matsukura M, Matsuda I (1982) Serum zinc and vitamin E concentrations in handicapped children treated with anticonvulsants. Dev Pharmacol Ther 5:109\u2013113","journal-title":"Dev Pharmacol Ther"},{"key":"9003_CR39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2125.1978.tb01643.x","volume":"5","author":"GD Schott","year":"1978","unstructured":"Schott GD, Delves HT (1978) Plasma zinc levels with anticonvulsant therapy. Br J Clin Pharmacol 5:279\u2013280","journal-title":"Br J Clin Pharmacol"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-011-9003-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-011-9003-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-011-9003-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T23:56:26Z","timestamp":1592351786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-011-9003-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9003"],"URL":"https:\/\/doi.org\/10.1007\/s12011-011-9003-3","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}